Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Macular Degeneration: Data From an Observational Study

Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2016.08.016
Full Text
Abstract

Available in full text

Categories
Ophthalmology
Date
Authors
Publisher

Elsevier BV